Outcomes similar with partial, whole breast irradiation

August 24, 2012
Outcomes similar with partial, whole breast irradiation
Accelerated partial breast irradiation yields five-year clinical outcomes and patterns of failure similar to those achieved with whole breast irradiation, with excellent three-year survival for women who develop an ipsilateral breast tumor recurrence, according to a study published in the Sept. 1 issue of Cancer.

(HealthDay)—Accelerated partial breast irradiation (APBI) yields five-year clinical outcomes and patterns of failure similar to those achieved with whole breast irradiation (WBI), with excellent three-year survival for women who develop an ipsilateral breast tumor recurrence (IBTR), according to a study published in the Sept. 1 issue of Cancer.

Chirag Shah, M.D., of the William Beaumont Hospital in Royal Oak, Mich., and colleagues conducted a five-year study involving 1,440 patients with early-stage breast cancer (1,255 with [IBC], 194 with in situ [DCIS]) who underwent breast-conserving therapy (BCT) using ABPI.

The researchers found that 3.5 percent of patients developed an IBTR, for a five-year actuarial rate of 3.61 percent. Of the 50 recurrences, 36 were new primary cancers and 14 were recurrences of the index lesion. The vast majority of recurrences (78 percent) were IBC, and 22 percent were DCIS. After recurrence, 74 percent of women underwent a salvage mastectomy and 26 percent underwent a second BCT procedure. Tamoxifen was given as adjuvant therapy in 16 percent, and 12 percent received systemic chemotherapy. Three years after IBTR, the disease-free survival rate was 58.7 percent, cause-specific survival was 92.1 percent, and overall survival was 80.5 percent.

"In conclusion, with five years of follow-up in a large group of selected patients, APBI produced clinical outcomes and patterns of failure comparable to those reported with WBI," the authors write. "Those patients who developed an IBTR after APBI had excellent three-year survival outcomes after salvage treatment, which, again, was similar to the outcomes of those who developed an IBTR after WBI."

One author disclosed financial ties to Hologic Inc.

Explore further: Older women may not benefit from radiotherapy after breast surgery

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Older women may not benefit from radiotherapy after breast surgery

August 21, 2012
A Rhode Island Hospital radiation oncologist says in a new editorial that research exploring the impact of radiotherapy in older women with low risk of breast cancer recurrence has little effect on actual clinical decisions. ...

APBI associated with more mastectomies, toxicities, complications, compared to traditional radiation

May 1, 2012
Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate ...

Chemotherapy is as effective before breast cancer surgery as after

September 8, 2011
Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, ...

Study finds side effects, complications, mastectomy more likely after partial breast irradiation

December 7, 2011
Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate ...

Breast cancer surgery patients benefit from adding radiation therapy

June 4, 2011
Additional radiation treatment improves disease free survival lessening the chance of cancer recurring in women with early breast cancer who have had breast conserving surgery (lumpectomy), interim results of a new study ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.